期刊文献+

Cachexia and pancreatic cancer: Are there treatment options? 被引量:4

Cachexia and pancreatic cancer: Are there treatment options?
下载PDF
导出
摘要 Cachexia is frequently described in patients with pancreatic ductal adenocarcinoma(PDAC)and is associated with reduced survival and quality of life.Unfortunately,the therapeutic options of this multi-factorial and complex syndrome are limited.This is due to the fact that,despite extensive preclinical and clinical research,the underlying pathological mechanisms leading to PDAC-associated cachexia are still not fully understood.Furthermore,there is still a lack of consensus on the definition of cachexia,which complicates the standardization of diagnosis and treatment as well as the analysis of the current literature.In order to provide an efficient therapy for cachexia,an early and reliable diagnosis and consistent monitoring is required,which can be challenging especially in obese patients.Although many substances have been tested in clinical and preclinical settings,so far none of them have been proven to have a long-term effect in ameliorating cancer-associated cachexia.However,recent studies have demonstrated that multidimensional therapeutic modalities are able to alleviate pancreatic cancerassociated cachexia and ultimately improve patients’outcome.In this current review,we propose a stepwise and pragmatic approach to facilitate and standardize the treatment of cachexia in pancreatic cancer patients.This strategy consists of nutritional,dietary,pharmacological,physical and psychological methods. Cachexia is frequently described in patients with pancreatic ductal adenocarcinoma (PDAC) and is associated with reduced survival and quality of life. Unfortunately, the therapeutic options of this multi-factorial and complex syndrome are limited. This is due to the fact that, despite extensive preclinical and clinical research, the underlying pathological mechanisms leading to PDAC-associated cachexia are still not fully understood. Furthermore, there is still a lack of consensus on the definition of cachexia, which complicates the standardization of diagnosis and treatment as well as the analysis of the current literature. In order to provide an efficient therapy for cachexia, an early and reliable diagnosis and consistent monitoring is required, which can be challenging especially in obese patients. Although many substances have been tested in clinical and preclinical settings, so far none of them have been proven to have a long-term effect in ameliorating cancer-associated cachexia. However, recent studies have demonstrated that multidimensional therapeutic modalities are able to alleviate pancreatic cancer-associated cachexia and ultimately improve patients’ outcome. In this current review, we propose a stepwise and pragmatic approach to facilitate and standardize the treatment of cachexia in pancreatic cancer patients. This strategy consists of nutritional, dietary, pharmacological, physical and psychological methods.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第28期9361-9373,共13页 世界胃肠病学杂志(英文版)
关键词 CACHEXIA PANCREATIC NEOPLASMS NUTRITIONAL support Cachexia Pancreatic neoplasms Nutritional support Gastrointestinal neoplasms
  • 相关文献

参考文献10

  • 1Jeannine Bachmann,MarkusW. Büchler,Helmut Friess,MarcE. Martignoni.Cachexia in Patients with Chronic Pancreatitis and Pancreatic Cancer: Impact on Survival and Outcome[J].Nutrition and Cancer.2013(6)
  • 2Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 3Sílvia Busquets,Roberto Serpe,Míriam Toledo,Angélica Betancourt,Enrica Marmonti,Marcel Orpí,Fabrizio Pin,Eva Capdevila,Clelia Madeddu,Francisco J. López-Soriano,Giovanni Mantovani,Antonio Macciò,Josep M. Argilés.l -Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer[J].Clinical Nutrition.2012(6)
  • 4Thomas Pausch,Werner Hartwig,Ulf Hinz,Thomas Swolana,Bogota D. Bundy,Thilo Hackert,Lars Grenacher,Markus W. Büchler,Jens Werner.Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer[J].Surgery.2012(3)
  • 5Jaros?aw Szefel,Wies?aw Kruszewski,Maciej Ciesielski,Mariusz Szajewski,Krzysztof Kawecki,Ewa Aleksandrowicz?Wrona,Jerzy Jankun,Wies?awa ?ysiak-Szyd?owska.L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolicdisorders in cancer cachexia[J].Oncology Reports.2012(1)
  • 6Kenneth C.H. Fearon,David J. Glass,Denis C. Guttridge.Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways[J].Cell Metabolism.2012(2)
  • 7Clelia Madeddu,Mariele Dessì,Filomena Panzone,Roberto Serpe,Giorgia Antoni,Maria Chiara Cau,Lorenza Montaldo,Quirico Mela,Marco Mura,Giorgio Astara,Francesca Maria Tanca,Antonio Macciò,Giovanni Mantovani.Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome[J].Clinical Nutrition.2011(2)
  • 8Josep Argilés,Sílvia Busquets,Francisco López-Soriano,Paola Costelli,Fabio Penna.Are there any benefits of exercise training in cancer cachexia?[J].Journal of Cachexia Sarcopenia and Muscle.2012(2)
  • 9Trevor J Bayliss,Jeff T Smith,Michael Schuster,Konstantin H Dragnev,James R Rigas.A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer[J].Expert Opinion on Biological Therapy.2011(12)
  • 10Kenneth Fearon,Florian Strasser,Stefan D Anker,Ingvar Bosaeus,Eduardo Bruera,Robin L Fainsinger,Aminah Jatoi,Charles Loprinzi,Neil MacDonald,Giovanni Mantovani,Mellar Davis,Maurizio Muscaritoli,Faith Ottery,Lukas Radbruch,Paula Ravasco,Declan Walsh,Andrew Wilcock,Stein Kaasa,Vickie E Baracos.Definition and classification of cancer cachexia: an international consensus[J].Lancet Oncology.2011(5)

共引文献130

同被引文献1

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部